Immune checkpoint inhibitor therapy is associated with a decreased risk of developing melanoma brain metastases
Abstract Background Despite recent advancements in metastatic melanoma treatment, the emergence of melanoma brain metastases (MBM) continues to pose a challenge. This study aimed to explore factors associated with MBM development. Methods This retrospective study included patients diagnosed with adv...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Nature Portfolio
2025-04-01
|
| Серія: | BJC Reports |
| Онлайн доступ: | https://doi.org/10.1038/s44276-025-00137-2 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|